Three genes whose expression had been significantly elevated by EBV were cyclin-dependent kinase 1 (CDK1), cyclin B1 (CCNB1), and survivin [29]; this finding in addition to our knowledge about survivin implication in cancer indicates that its application for graft promotion should be cautiously studied to avoid inducing malignancies. This evidence concerns the gene BIRC5 and cancer.